Development of Potent Nanosized Isatin-isonicotinohydrazide Hybrid for Management of Mycobacterium Tuberculosis

Faculty Pharmacy Year: 2022
Type of Publication: ZU Hosted Pages: 121369
Authors:
Nora Gamal Mohamed Abdallah Essa
Journal: International Journal of Pharmaceutics Elsevier B.V. Volume: Volume 612
Keywords : Development , Potent Nanosized Isatin-isonicotinohydrazide Hybrid , Management    
Abstract:
Inspired by the antitubercular activity of isoniazid (INH) and 5-bromoisatin, isatin–INH hybrid (WF-208) has been synthesized as a potent agent against multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of M. tuberculosi
    
     
 
       

Author Related Publications

  • Nora Gamal Mohamed Abdallah Essa, "Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations", MDPI, 2022 More
  • Nora Gamal Mohamed Abdallah Essa, "Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides", Elsevier Inc, 2014 More
  • Nora Gamal Mohamed Abdallah Essa, "Buccoadhesive tablets for delivery of verapamil Hcl: Design, in-vitro analysis and in-vivo evaluation", Bull. Pharm. Sci., Assiut University, 2012 More
  • Nora Gamal Mohamed Abdallah Essa, "New approach for administration of doxazosin mesylate: comparative study between liquid and solid self-nanoemulsifying drug delivery systems", JK Welfare & Pharmascope Foundation, 2021 More
  • Nora Gamal Mohamed Abdallah Essa, "Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study", Wiley, 2019 More

Department Related Publications

  • Fakhreldeen Soliman Ghazy Shehata, "Solid dispersion approach for optimized bioavailability of sulpiride", Lat.Am.j.Pharm, 2013 More
  • Tamer Mohamed Sayed Ahmed Shehata, "Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin", AAPS, 2015 More
  • Nagia] Ahmed Alameen Elmgrab, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
  • Azza Ali Hassan Solyman, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
  • Eman Gomaa Ahmed alsayed, "A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases", european journal of pharmaceutical sciencesl, 2024 More
Tweet